https://doi.org/10.55788/28e6066d
Style-AF (NCT05563142) was a prospective, non-blinded, randomised trial in patients with catheter ablation for atrial fibrillation with 1 or 2 venous punctures performed at 3 high-volume centres in Germany [1]. Participants who underwent successful ultrasound-guided venous puncture of the groin were randomised to either a venous vascular closure system (n=63) or a figure-of-8 suture following manual compression (n=62). Prof. Roland Tilz (University Heart Center Lübeck, Germany) presented the primary efficacy endpoint, which was time to ambulation (defined as time from removal of the final closure device or removal of the final sheath to time when the patient can stand and walk 20 feet without evidence of venous rebleeding from the femoral access site), as well as the primary safety endpoint consisting of major periprocedural adverse events.
The time to ambulation in the vascular closure group was significantly shorter than in the figure-of-8 group (109 vs 269 minutes; P<0.001), with no difference in the rates of major periprocedural complications (0% vs 0%; P<0.001). The time to haemostasis (1 vs 5 minutes) and time to discharge eligibility (270 vs 340 minutes) was also significantly shorter in the vascular closure group (P<0.001 for both comparisons). Minor complications were reported in 20.6% of participants in the vascular closure group and 35.5% of participants in the figure-of-8 group (P=0.075), with significantly lower rates of groin haematoma <6 cm in the vascular closure group (9.5% vs 24.2%; P=0.033).
“Following atrial fibrillation ablation, the use of a vascular closure device results in a significantly shorter time to ambulation and time to discharge eligibility,” concluded Prof. Tilz, while “the use of manual compression and figure-of-8 suture showed a trend towards increasing incidence of minor bleeding complications.”
- Tilz R, et al. Venous vascular closure system versus manual compression following single shot device AF ablation - The Style AF study. Late-Breaking Science: clinical. EHRA Congress 2024, 7–9 April, Berlin, Germany.
Copyright ©2024 Medicom Medical Publishers
Posted on
Previous Article
« Advantage of PREVENTIVE ablation plus implantable cardioverter-defibrillator in ischaemic cardiomyopathy Next Article
Personalised LAWT-guided ablation non-inferior to CLOSE protocol for paroxysmal atrial fibrillation »
« Advantage of PREVENTIVE ablation plus implantable cardioverter-defibrillator in ischaemic cardiomyopathy Next Article
Personalised LAWT-guided ablation non-inferior to CLOSE protocol for paroxysmal atrial fibrillation »
Table of Contents: EHRA 2024
Featured articles
PIRECNA: Cardioneuroablation is feasible for vagally-induced atrioventricular block
ARTESiA: Stroke risk unaffected by subclinical atrial fibrillation duration
Personalising Ablation Techniques
Ablate-by-LAW: CT-determined left atrial wall thickness for ablation titration in atrial fibrillation
Personalised LAWT-guided ablation non-inferior to CLOSE protocol for paroxysmal atrial fibrillation
Style-AF: Improved outcomes with vascular closure versus figure-of-eight suture
Advantage of PREVENTIVE ablation plus implantable cardioverter-defibrillator in ischaemic cardiomyopathy
ASTRO AF: No benefit of staged left atrial appendage isolation cryoballoon ablation over radiofrequency ablation
Innovative Ablation Strategies
Pulsed-field ablation vs high-power short-duration radiofrequency in paroxysmal AF
CryoCure-VT: Endocardial ultra-low temperature cryoablation effective in sustained monomorphic ventricular tachycardia
PIRECNA: Cardioneuroablation is feasible for vagally-induced atrioventricular block
MRI head-to-head comparison of lesion quality following various ablation techniques
“Single-shot” conformable catheter shows promising efficacy in paroxysmal atrial fibrillation
Post-Ablation Recurrence
AF burden versus classical AF classification in predicting arrhythmia recurrence
ARTESiA: Stroke risk unaffected by subclinical atrial fibrillation duration
Ablation strategy and the number of repeat procedures not associated with atrial fibrillation recurrence
Factors associated with negative outcomes in post-operative atrial fibrillation
Arrhythmia Technologies
Smartphone rhythm monitoring optimises AF management following cardiac surgery
SMART-AV and SMART-CRT: Improved cardiac outcomes with algorithm-adapted atrioventricular delay
Premature battery depletion can affect a quarter of subcutaneous cardioverter defibrillators
New atrial fibrillation associated with a high risk of major cardiovascular outcomes
Related Articles
January 11, 2023
First-line ablation limits progression to persistent AF
© 2024 Medicom Medical Publishers. All rights reserved. Terms and Conditions | Privacy Policy
HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com